GlassScriptPhysician profile
Kenneth M Rosenstein
NPI 1376792606
$1,785.59
in general payments reported to CMS, 2019-2025
18 companies · $381 in 2025
The $381 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $202 · 2021: $269 · 2022: $261 · 2023: $191 · 2024: $481 · 2025: $381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,053.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,053.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $285.72 | 2019-2024 | Dupixent |
| Glaxosmithkline, LLC. | $273.58 | 2021-2025 | Nucala |
| Genzyme Corporation | $240.34 | 2021-2025 | |
| Stryker Corporation | $180.59 | 2019-2023 | Xpress Ent Dilation System |
| Intersect Ent, INC. | $151.59 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $132.16 | 2023-2025 | Tezspire, Fasenra |
| Aerin Medical INC. | $84.12 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $76.96 | 2022-2025 | Takhzyro, Cuvitru |
| Grifols USA, LLC | $52.10 | 2024 | Xembify |
| Csl Behring | $50.04 | 2021-2025 | Andembry |
| Alk-Abello, INC | $49.87 | 2021-2022 | |
| Genentech USA, INC. | $42.63 | 2025 | Xolair |
| Kaleo, INC. | $41.28 | 2022-2024 | Auvi-Q |
| Aimmune Therapeutics, INC. | $40.65 | 2021-2022 | |
| Greer Laboratories, INC. | $25.18 | 2025 | Oralair |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $22.88 | 2021 | |
| Medtronic, INC. | $21.15 | 2025 | Propel |
| Amgen INC. | $14.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Rosenstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.